Duodenal Ulcer: all 77 studies
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingNCT07730138Phase 3
- Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICURecruitingNCT07399054
- Prevention of Postoperative Hernias in Emergency SurgeryRecruitingNCT06815822
- Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy VolunteersRecruitingNCT06098742Not applicable
- Web-based International Register of Emergency Surgery and TraumaRecruitingNCT03643718
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCompletedNCT03553563Phase 3Results posted
- Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"CompletedNCT03219723Results posted
- Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"CompletedNCT03214952Results posted
- Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"CompletedNCT03214198Results posted
- Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"CompletedNCT03214094Results posted
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050359Phase 3Results posted
- Stress Ulcer Prophylaxis in the Intensive Care UnitCompletedNCT02467621Phase 4Results posted
- A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesCompletedNCT02153398Phase 3Results posted
- Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]CompletedNCT02151786Results posted
- Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory DrugsCompletedNCT02099708Results posted
- Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose AspirinCompletedNCT02099682Results posted
- Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)CompletedNCT01398410Phase 2/3Results posted
- Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)CompletedNCT01397448Phase 2/3Results posted
- Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose AspirinCompletedNCT01069939Phase 3Results posted
- Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory DrugsCompletedNCT00787254Phase 3Results posted
- A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersTerminatedNCT00762359Phase 3Results posted
- Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced UlcerCompletedNCT00595517Phase 3Results posted
- Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDCompletedNCT00542789Phase 3Results posted
- Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)CompletedNCT00441727Phase 3Results posted
- The New Transition Factors to Surgery of Duodenal PerforationCompletedNCT06651008
- Optimizing Stress Ulcer Prophylaxis Practices and Reducing Associated Costs in Intensive Care Units: a Nonrandomized Controlled StudyCompletedNCT06586333Not applicable
- Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy VolunteersCompletedNCT06552624Not applicable
- Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care UnitCompletedNCT06225167
- A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"CompletedNCT06165237Phase 1
- A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult VolunteersCompletedNCT05959499Phase 1
- A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult VolunteersCompletedNCT05959486Phase 1
- Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT05579444
- A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal UlcerCompletedNCT05208268
- Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal UlcerCompletedNCT05010954Phase 3
- Scoring System in Predicting Perforated Duodenal Ulcer Morbidity and Mortality in BpkihsCompletedNCT04994184
- Incentive Spirometry and Upper Abdominal Laparoscopic SurgeryCompletedNCT04716166Not applicable
- To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.Active, not recruitingNCT04702542Not applicable
- A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.CompletedNCT04503629Phase 2
- Early Oral Feeding vs Traditional Post-operative Care In Emergency Abdominal SurgeriesCompletedNCT04431037Not applicable
- A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.Status unknownNCT04215653Phase 3
- The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal UlcersCompletedNCT03342456Phase 4
- A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNAStatus unknownNCT03057171
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedNCT02847455Phase 2/3
- Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet AgentsTerminatedNCT02840929Not applicable
- Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose AspirinCompletedNCT02423187
- Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCTCompletedNCT02166008Phase 2/3
- Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer BleedingStatus unknownNCT02108756Not applicable
- BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsCompletedNCT01964131Phase 1
- Sublingual Administration of PPIStatus unknownNCT01926600
- Concomitant Therapy of H. PyloriStatus unknownNCT01922765Phase 4
- Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed ConditionsCompletedNCT01847417Phase 1
- Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting ConditionsCompletedNCT01847404Phase 1
- Nexium Capsules LDA Specific Clinical Experience InvestigationCompletedNCT01729182
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin TherapyCompletedNCT01568398Phase 3
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) TherapyCompletedNCT01568385Phase 3
- Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience InvestigationCompletedNCT01562600
- Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal UlcersCompletedNCT01471496Not applicable
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01456260Phase 3
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01456247Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01452763Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01452750Phase 3
- Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal UlcerCompletedNCT01452724Phase 3
- Nexium Capsules Helicobacter Pylori Specific Clinical Experience InvestigationCompletedNCT01435525
- Nexium Capsules Clinical Experience InvestigationCompletedNCT01434485
- Helicobacter Pylori Eradication Treatment in Patients With Duodenal UlcersCompletedNCT01199536
- Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different AntiplateletsStatus unknownNCT01037491Not applicable
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)CompletedNCT00953381Phase 2
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)CompletedNCT00952978Phase 3
- Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori InfectionCompletedNCT00854451Phase 4
- MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)CompletedNCT00543868Phase 2
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy VolunteersCompletedNCT00284908Phase 1
- Effect of Prevacid on Prostaglandin Levels in Patient With Stress UlcerCompletedNCT00239551Phase 4
- Cytokine Gene Polymorphisms in Gastric DiseasesStatus unknownNCT00197470Not applicable
- Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3
- Lymphocytic Subsets and Cytokine Production With H. Pylori InfectionCompletedNCT00173953Not applicable
- Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3
- Helicobacter Pylori Eradication With a New Sequential TreatmentCompletedNCT00132171Phase 3